Purchase Order W9124925PA007
- Not listed
- The U.S. Army Criminal Investigation Command (CID) awarded a firm fixed-price purchase order valued at $267,622 to Qiagen, LLC for molecular diagnostics products and services, effective January 1, 2026, with completion by December 31, 2026. This child contract, issued without set-aside designation, will be performed at Fort Gillem, Georgia. Qiagen, LLC, a Germantown, Maryland-based manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions, is a foreign-owned...
- This is a $407,205.84 firm-fixed-price purchase order contract awarded by the U.S. Army Criminal Investigation Command (CID) to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract is structured as a Master Service Agreement with a period of performance through January 1, 2024. Qiagen, LLC provides a range of molecular diagnostics products, reagents, and services to support federal agencies' biomedical research, public health, law enforcement, and...
- The U.S. Army Criminal Investigation Command awarded a BPA (Blanket Purchase Agreement) call valued at $49,969.74 to Qiagen, LLC on December 17, 2025, with an ultimate completion date of January 17, 2026. This firm fixed-price call is issued under an existing BPA vehicle and will be performed at Fort Gillem, Georgia. The award carries no set-aside designation, reflecting Qiagen's competitive standing in the open federal marketplace for specialized molecular diagnostics products and services....
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Criminal Investigation Command (CID) to Qiagen, LLC, a division of Qiagen N.V. The contract, valued at $248,800.50, is for the provision of QIAGEN MASTER SERVICE products and services. The contract has an ultimate completion date of December 31, 2024. Qiagen, as a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, has previously supported federal agencies'...
- Qiagen, LLC, a Germantown, Maryland-based molecular diagnostics company, was awarded a Blanket Purchase Agreement call valued at $8,977.30 on December 5, 2025, by the Criminal Investigation Command, a Defense agency component. This firm fixed-price contract, designated as QIAGEN BPA CALL #1, is a child award under a larger blanket purchase agreement vehicle and does not utilize a set-aside designation. The work is to be performed at Fort Gillem, Georgia, with an ultimate completion date of...
- This is a firm fixed-price purchase order awarded by the U.S. Army Criminal Investigation Command to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The $51,033.00 contract is for a maintenance agreement on Qiagen's EZ1 instruments. It does not have a set-aside designation. Qiagen has established itself as a critical supplier of advanced scientific technologies to numerous government agencies, including the Department of Defense,...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Criminal Investigation Command (CID) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract has a ceiling value of $149,999 and a performance period ending on October 31, 2016. The contract is for the procurement of a QIAGILITY HEPA / UV system, which is a laboratory automation instrument used for sample preparation and processing. Qiagen is an experienced federal contractor,...
- The Criminal Investigation Command (CID) awarded a Blanket Purchase Agreement (BPA) call to Qiagen, LLC on September 5, 2025, with a ceiling value of $21,243.00. This firm fixed-price contract call represents a task order under an existing BPA vehicle and will be performed at Fort Gillem, Georgia through September 30, 2025. The award was made without a set-aside designation, reflecting Qiagen's competitive standing as a specialized supplier of molecular diagnostics products and services. Qiagen,...
- Qiagen, LLC was awarded a $49,750.32 firm fixed price call against the Department of the Army Criminal Investigation Command's Blanket Purchase Agreement to deliver EZ1 & 2 DNA INVESTIGATOR KITS (catalog number 952034) for use at Fort Gillem, Georgia. Performance is required by March 28, 2023. As the prime contractor, Qiagen will utilize its parent company Qiagen N.V.'s resources to complete the contract. No set-aside designation was applied to this procurement for these DNA analysis...
- This is a $13,858 firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. The contract is for the maintenance of QIAGEN laboratory equipment. It does not have a set-aside designation and has an ultimate completion date of May 14, 2028. Qiagen is a...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Criminal Investigation Command (CID) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The $221,879.00 contract is for QIAGEN MAINTENANCE SERVICE at Fort Gillem, GA for the period of January 1, 2025 to December 31, 2025. No set-aside designation was used for this award. Qiagen, LLC is a division of the international biotechnology company Qiagen N.V. and has established itself as a critical supplier of advanced scientific technologies to numerous government agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Defense, and Federal Bureau of Investigation. The company holds several significant federal Indefinite Delivery Vehicles (IDVs) across multiple agencies for the provision of specialized molecular diagnostics products, reagents, and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 4/10/25 | |
| Not listed | Not listed | $221.9k | 2/27/25 |